Bad Blood
Secrets and Lies in a Silicon Valley Startup
Knopf Doubleday Publishing Group · Print & ebook · January 28, 2020
NATIONAL BESTSELLER • The gripping story of Elizabeth Holmes and Theranos—one of the biggest corporate frauds in history—a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist.
We earn from qualifying purchases.
- Who it’s for
- A gripping, carefully reported account of Silicon Valley ambition—and the damage when its promises fail.
- Genres
- Cons, Hoaxes & Scams, White-Collar Crime, Business Lives
- Published
- Knopf Doubleday Publishing Group, January 28, 2020
Nearest books
Matched by what the books are about, then ordered by what their readers also loved.
I'll Be Gone in the DarkMichelle McNamara, Gabra Zackman52% match
The HoldoutAbby Craden, Graham Moore55% match
Elon MuskAshlee Vance57% matchShares Business Lives
Careless PeopleSarah Wynn-Williams57% matchShares Business Lives
No More TearsGardiner Harris53% matchShares White-Collar Crime
Catch and KillRonan Farrow, Little, Brown & Company55% match
For younger readers: Steve Jobs: the Man Who Thought Different, Admission, The Sacred Lies of Minnow Bly
Start with three books, and this one can be the first.
Members get a new edition every morning: a route out from their books to essays, research and talks, with the reason for each.
Start with this bookAbout this book
NATIONAL BESTSELLER • The gripping story of Elizabeth Holmes and Theranos—one of the biggest corporate frauds in history—a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist. With a new Afterword covering her trial and sentencing, bringing the story to a close. “Chilling ... Reads like a thriller ...
Continue reading
Carreyrou tells [the Theranos story] virtually to perfection.” —The New York Times Book Review In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.
Promises Under Pressure
A gripping, carefully reported account of Silicon Valley ambition—and the damage when its promises fail.
Come here for
- A rigorously reported account of ambition, hubris, and corporate fraud
- The uneasy collision of startup promises and patient risk
Expect
- A true-crime story rooted in business and medical technology
- An afterword covering Holmes’s trial and sentencing
Where it sits
| Cons, Hoaxes & Scams | 52% |
|---|---|
| White-Collar Crime | 52% |
| Business Lives | 43% |
Percentages are BookFrontier’s reading of the book.
Publisher categories
- Venture Capital
- Starting a Business
- Biomedical Engineering
- Authors
- John Carreyrou
- Publisher
- Knopf Doubleday Publishing Group
- Published
- January 28, 2020
- Format
- Print & ebook
- Reading lane
- Venture Capital